These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design. Cheng H; Linhares BM; Yu W; Cardenas MG; Ai Y; Jiang W; Winkler A; Cohen S; Melnick A; MacKerell A; Cierpicki T; Xue F J Med Chem; 2018 Sep; 61(17):7573-7588. PubMed ID: 29969259 [TBL] [Abstract][Full Text] [Related]
13. Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond. Ai Y; Hwang L; MacKerell AD; Melnick A; Xue F J Med Chem; 2021 Apr; 64(8):4333-4358. PubMed ID: 33844535 [TBL] [Abstract][Full Text] [Related]
14. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154 [TBL] [Abstract][Full Text] [Related]
15. Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket. Lloyd MG; Huckvale R; Cheung KJ; Rodrigues MJ; Collie GW; Pierrat OA; Gatti Iou M; Carter M; Davis OA; McAndrew PC; Gunnell E; Le Bihan YV; Talbot R; Henley AT; Johnson LD; Hayes A; Bright MD; Raynaud FI; Meniconi M; Burke R; van Montfort RLM; Rossanese OW; Bellenie BR; Hoelder S J Med Chem; 2021 Dec; 64(23):17079-17097. PubMed ID: 34846884 [TBL] [Abstract][Full Text] [Related]